On 26 May, during the 76th World Health Assembly in Geneva, IFPMA provided a statement on agenda items 13.1: Reorienting health systems to primary health care as a resilient foundation for universal health coverage and preparations for a high-level meeting of the United Nations General Assembly on universal health coverage and 13.2: Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases, and mental health.

COVID-19 has been a wake-up call in showing that UHC is fundamental to global health security, economic security, and health equity. The “perfect storm” that chronic conditions and pandemics create underscores the need for strong and resilient health systems.

Clearly, no single government, organization, or sector can achieve UHC on its own, particularly when countries are facing an unparalleled combination of external shocks. As part of the UHC2030 Private Sector Constituency, we support the Action Agenda and its rallying calls to governments. Prevention, treatment, diagnosis, and care must be prioritized in essential benefits packages for NCDs and communicable diseases such as HIV, with primary healthcare being the foundation of UHC. The innovative pharmaceutical industry stands with the global health community to support countries in accelerating their efforts to achieve UHC.

About IFPMA

IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere.

To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health.

ifpma.org

Media Contact

Elliot Dunster e.dunster@ifpma.org